New approach to combat cancer by reactivating natural RNA kill switch

FHS
March 14, 2025
10:20 pm

Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different versions of a film.

Selinexor by Karyopharm Therapeutics for Osteosarcoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 8, 2023

Is climate change turning up the heat on China’s aging population?

Rising temperatures and an aging population in China exacerbate heat-related mortality risks, new study finds. The research highlights the urgent need for policies that address

October 3, 2023

Do neighborhood-level disparities in breast cancer–specific survival remain after accounting for individual, tumor, and treatment characteristics?

The role of neighborhood-level disparities in determining shorter breast cancer-specific survival.

April 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.